Institute of Pathology

Normal Variants in Magnetoencephalography (2020) Rampp S, Kakisaka Y, Shibata S, Wu X, Rössler K, Buchfelder M, Burgess RC Journal article Acute Kidney Allograft Injury Following Vitamin C Administration for Septic Shock (2020) Mahling M, Köppen M, Mühlbacher T, Amann KU, Königsrainer A, Heyne N, Häberle H, et al. Journal article High stroma T-cell infiltration is associated with better survival in stage pT1 bladder cancer (2020) Hülsen S, Lippolis E, Ferrazzi F, Otto W, Distel L, Fietkau R, Denzinger S, et al. Journal article New oleoyl hybrids of natural antioxidants: Synthesis and in vitro evaluation as inducers of apoptosis in colorectal cancer cells (2020) Carullo G, Mazzotta S, Koch AM, Hartmann K, Friedrich O, Gilbert D, Vega-Holm M, et al. Journal article Tumour-infiltrating inflammatory cells in early breast cancer: An underrated prognostic and predictive factor? (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Journal article Afferent renal innervation in anti-Thy1.1 nephritis in rats (2020) Rodionova K, Veelken R, Hilgers KF, Paulus EM, Linz P, Fischer MJ, Schenker M, et al. Journal article Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society (2020) Haas M, Seshan SV, Barisoni L, Amann KU, Bajema IM, Becker JU, Joh K, et al. Journal article Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2020) Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Götz TI, Soare A, Cordes M, et al. Journal article Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article